Famotidine versus omeprazole, in combination with amoxycillin and tinidazole, for eradication of Helicobacter pylori infection

被引:12
|
作者
Hsu, CC [1 ]
Chen, JJ [1 ]
Hu, TH [1 ]
Lu, SN [1 ]
Changchien, CS [1 ]
机构
[1] Chi Mei Fdn Hosp, Dept Internal Med, Div Gastroenterol, Tainan 710, Taiwan
关键词
H-2-receptor antagonist; Helicobacter pylori infection; metronidazole resistance; proton pump inhibitor; triple therapy;
D O I
10.1097/00042737-200108000-00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background Eradication regimens combining two antibiotics with a proton pump inhibitor have been studied intensively. In contrast, only a few studies have focused on the possible role of H-2-receptor antagonists in eradication therapy. The mechanism involved in the synergy between antibiotics and proton pump inhibitors is still controversial. Objectives To compare the results of two triple-therapy regimens, different only in the antisecretory drugs used, in patients with Helicobacter pylori infection, and to assess the impact of primary resistance to metronidazole on treatment outcome. Methods A total of 120 patients with peptic ulcer and nonulcer dyspepsia were randomly assigned to a 2-week course of either: famotidine 40 mg twice a day, amoxycillin 1 g twice a day and tinidazole 500 mg twice a day (FAT group; n = 60); or omeprazole 20 mg twice a day, amoxycillin 1 g twice a day and tinidazole 500 mg twice a day (OAT group; n = 60). Upper endoscopy was performed prior to treatment and at least 4 weeks after completion of treatment and discontinuation of the antisecretory therapy. H. pylori status was assessed by a biopsy urease test, histology and culture. Results In the intention-to-treat analysis, eradication of H. pylori was achieved in 48 of the 60 patients (80%; 95% confidence interval: 70-90%) in the FAT group, compared to 50 of the 60 patients (83.3%; 95% confidence interval: 74-93%) in the OAT group. In the per protocol analysis, eradication therapy was achieved in 48 out of 53 patients (90.6%; 95% confidence interval: 83-98%) treated with FAT and 50 out of 57 patients (87.7%; 95% confidence interval: 79-96%) treated with OAT (not significant). The primary metronidazole resistance was present in 28.8% of strains. Overall, per protocol eradication rates in strains resistant and susceptible to metronidazole were 83.3% and 91.3% respectively (P > 0.05). Conclusions Two-week courses of either high-dose famotidine or omeprazole, both combined with amoxycillin and tinidazole, are equally effective for eradication of H. pylori infection. In a 2-week triple therapy, metronidazole resistance has no significant impact on eradication rates. Eur J Gastroenterol Hepatol 13:921-926 (C) 2001 Lippincott Williams & Wilkins.
引用
收藏
页码:921 / 926
页数:6
相关论文
共 50 条
  • [1] Omeprazole plus azithromycin and either tinidazole or amoxycillin for the eradication of Helicobacter pylori infection
    Anagnostopoulos, G
    Kostopoulos, P
    Margantinis, G
    Tsiakos, S
    Arvanitidis, D
    GUT, 2002, 51 : A102 - A102
  • [2] Omeprazole-amoxycillin versus omeprazole-amoxycillin-clarithromycin in the eradication of Helicobacter pylori
    Delchier, JC
    Elamine, I
    Goldfain, D
    Chaussade, S
    Barthelemy, P
    Idstrom, JP
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) : 263 - 268
  • [3] Famotidine versus omeprazole in combination with clarithromycin and metronidazole for eradication of Helicobacter pylori -: a randomized, controlled trial
    Gschwantler, M
    Dragosics, B
    Schütze, K
    Wurzer, H
    Hirschl, AM
    Pasching, E
    Wimmer, M
    Klimpfinger, M
    Oberhuber, G
    Brandstätter, G
    Hentschel, E
    Weiss, W
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1999, 13 (08) : 1063 - 1069
  • [4] Esomeprazole versus omeprazole for the eradication of Helicobacter pylori infection
    Anagnostopoulos, GK
    Tsiakos, S
    Margantinis, G
    Kostopoulos, P
    Arvanitidis, D
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2004, 38 (06) : 503 - 506
  • [5] Omeprazole plus azithromycin and either amoxicillin or tinidazole for eradication of Helicobacter pylori infection
    Anagnostopoulos, GK
    Kostopoulus, P
    Margantinis, G
    Tsiakos, S
    Arvanitidis, D
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2003, 36 (04) : 325 - 328
  • [6] Clarithromycin, omeprazole and amoxycillin combination for the treatment of Helicobacter pylori infection in China
    Yuan, SZ
    Su, H
    GUT, 1997, 41 : A210 - A210
  • [7] OMEPRAZOLE VERSUS CLARITHROMYCIN AND OMEPRAZOLE FOR ERADICATION OF HELICOBACTER-PYLORI INFECTION
    GREAVES, RG
    CAYLA, R
    MENDELSON, MG
    LAMOULIATTE, H
    GUMMET, PA
    BARON, JH
    MEGRAUD, F
    LOGAN, RH
    MISIEWICZ, JJ
    GASTROENTEROLOGY, 1994, 106 (04) : A84 - A84
  • [8] Low-dose omeprazole plus clarithromycin and either tinidazole or amoxycillin for Helicobacter pylori infection
    Tursi, A
    Cammarota, G
    Montalto, M
    Papa, A
    Veneto, G
    Cuoco, L
    Trua, F
    Branca, G
    Fedeli, G
    Gasbarrini, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) : 285 - 288
  • [9] Low eradication rates of Helicobacter pylori with omeprazole plus amoxycillin combination in a Turkish population
    Simsek, H
    Kadayifci, A
    Tatar, G
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1996, 91 (05): : 1062 - 1062
  • [10] Randomized study comparing omeprazole plus amoxycillin versus omeprazole plus clarithromycin for eradication of Helicobacter pylori
    Spinzi, G
    Bortoli, A
    Colombo, E
    Lesinigo, E
    Venturelli, R
    Terruzzi, V
    Imperiali, G
    Minoli, G
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (02) : 317 - 322